Yes, opioids can cause depression, and the risk increases with how often and how long you use them. People who take prescription opioids on a near-daily basis have up to a 40 percent greater risk of developing a new episode of depression compared to those who use them only occasionally. Even short-term use carries some risk: between 8 and 11 percent of people who used opioids for just 1 to 30 days developed depression within the following year.
How Opioids Change Brain Chemistry
Opioids work by binding to receptors in the brain that control pain, pleasure, and mood. When you take an opioid, it floods the brain’s reward system with feel-good signals, which is partly why these drugs are so effective at relieving pain and so prone to misuse. But over time, the brain adapts. It dials down its own natural production of the chemicals responsible for motivation, pleasure, and emotional stability. When the drug wears off, you’re left with a system that’s been recalibrated to function only with the drug present.
This recalibration affects the dopamine pathways tied to reward and motivation. Activities that once brought satisfaction, like eating a good meal, exercising, or spending time with people you care about, can start to feel flat. The brain’s reward circuitry becomes sluggish without the opioid stimulus, creating a persistent low mood that closely mirrors clinical depression.
Some synthetic opioids also interfere with serotonin and norepinephrine, two other brain chemicals essential for mood regulation. Tramadol, for instance, is structurally similar to the antidepressant venlafaxine and blocks the reuptake of both serotonin and norepinephrine. Methadone does something similar. While blocking reuptake might sound like it would improve mood (that’s how many antidepressants work), the effect in opioid users is more complicated. The constant push and pull on these chemical systems can destabilize mood regulation rather than support it.
The Hormone Connection
Opioids suppress the hormonal system that controls sex hormone production. They act on the hypothalamus, a part of the brain that serves as the command center for hormone signaling, and reduce the release of signals that tell the body to produce testosterone and estrogen. This condition, called opioid-induced hypogonadism, is common in both men and women on long-term opioid therapy.
Low testosterone and estrogen don’t just affect libido and fertility. They directly contribute to depression, anxiety, fatigue, and a general sense of reduced well-being. If you’re taking opioids and experiencing depressive symptoms, this hormonal disruption could be a treatable underlying cause. A simple blood test can check your hormone levels, and the issue can sometimes be addressed even while continuing opioid therapy for pain management.
Dose and Duration Matter
The relationship between opioids and depression follows a dose-response pattern: the more you take and the longer you take it, the higher your risk. Near-daily users face the steepest increase in risk, with that 40 percent jump compared to occasional users. But the threshold for concern is lower than many people assume. Depression can emerge after just a few weeks of use, not only after months or years.
The CDC’s 2022 clinical practice guideline for opioid prescribing reflects this concern. It recommends that clinicians use validated screening tools for depression and anxiety before starting opioid therapy and at regular intervals afterward, typically every three months or more often for higher-risk patients. People with a history of depression, substance use disorder, or those taking higher doses are flagged for more frequent check-ins.
Depression During and After Withdrawal
Stopping opioids doesn’t immediately resolve the mood problems they create. Acute withdrawal from short-acting opioids like heroin begins 8 to 24 hours after the last dose and lasts 4 to 10 days. For longer-acting opioids like methadone, withdrawal starts 12 to 48 hours after the last dose and can stretch to 20 days. During this phase, anxiety, irritability, and depressed mood are common alongside the physical symptoms.
After the acute phase passes, many people enter a protracted withdrawal period that can last up to six months. This phase is characterized by a general feeling of reduced well-being and strong cravings. The depressive symptoms during this window are not just psychological. They reflect a brain that is still recalibrating its chemistry after months or years of opioid exposure. This extended timeline catches many people off guard. Feeling low weeks or even months after stopping opioids is a recognized part of recovery, not a sign that something else is wrong.
The Two-Way Relationship
The link between opioids and depression runs in both directions. Opioids can trigger depression in people who never had it before, and people with pre-existing depression are more vulnerable to developing problematic opioid use. Psychiatric disorders occur alongside opioid use disorder at a higher rate than with most other substance use disorders.
This creates a cycle that can be difficult to interrupt. Depression makes chronic pain feel worse, which increases the desire for pain relief, which leads to higher opioid use, which deepens the depression. Recognizing this pattern is the first step toward breaking it.
Treating Depression Linked to Opioid Use
The approach to treating opioid-related depression depends on whether you’re still taking opioids, tapering off, or in recovery. For people with opioid use disorder, the primary treatments (maintenance therapy with medications like buprenorphine or structured treatment programs) are associated with substantial improvements in depression on their own, even before any specific depression treatment is added.
Research supports a stepped approach. Depression is evaluated at the start of treatment, then monitored. If it doesn’t improve as opioid use stabilizes, targeted interventions are added. These can include therapy, particularly approaches designed for co-occurring pain and mood problems, or antidepressant medication. The key insight is that depression in this context often improves once the opioid situation is addressed, but not always. Some people need treatment for both conditions simultaneously.
For people on long-term opioid therapy for chronic pain who develop depression, checking hormone levels is a practical first step. If opioid-induced hormonal suppression is contributing, that can be treated directly. Optimizing the opioid regimen itself, using the lowest effective dose and exploring non-opioid pain management strategies, can also reduce the depressive burden over time.